ABSTRACT
Endemic Burkitt's lymphoma (BL) is considered to preferentially develop in equatorial Africa because of chronic co-infection with Epstein-Barr virus (EBV) and the malaria pathogen Plasmodium falciparum. The interaction and contribution of both pathogens in the oncogenic process are poorly understood. Earlier, we showed that immune activation with a synthetic Toll-like receptor 9 (TLR9) ligand suppresses the initiation of EBV lytic replication in primary human B cells. In this study we investigate the mechanism involved in the suppression of EBV lytic gene expression in BL cell lines. We show that this suppression is dependent on functional TLR9 and MyD88 signaling but independent of downstream signaling elements, including phosphatidylinositol-3 kinase, mitogen-activated protein kinases and nuclear factor-kappaB. We identified TLR9 triggering resulting in histone modifications to negatively affect the activation of the promoter of EBV's master regulatory lytic gene BZLF1. Finally, we show that P. falciparum hemozoin, a natural TLR9 ligand, suppresses induction of EBV lytic gene expression in a dose-dependent manner. Thus, we provide evidence for a possible interaction between P. falciparum and EBV at the B-cell level and the mechanism involved in suppressing lytic and thereby reinforcing latent EBV that has unique oncogenic potential.
Subject(s)
Burkitt Lymphoma/pathology , Herpesvirus 4, Human/genetics , Histones/metabolism , Toll-Like Receptor 9/metabolism , Trans-Activators/genetics , Transcription, Genetic , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , B-Lymphocytes/virology , Base Sequence , Burkitt Lymphoma/virology , Cell Death/drug effects , Cell Line, Tumor , CpG Islands/genetics , Hemeproteins/metabolism , Hemeproteins/pharmacology , Herpesvirus 4, Human/drug effects , Herpesvirus 4, Human/physiology , Humans , Ligands , Myeloid Differentiation Factor 88/genetics , Plasmodium falciparum/metabolism , Promoter Regions, Genetic/genetics , Protozoan Proteins/metabolism , Protozoan Proteins/pharmacology , Signal Transduction/drug effects , Transcription, Genetic/drug effects , Virus Activation/drug effectsABSTRACT
In the present study, the effects of 17beta-estradiol (E(2)) treatment on the expression of preprosomatostatin (PPSS) I, PPSS II', and PPSS II" mRNA in the hypothalamus and endocrine pancreas (Brockmann body), as well as the effects of E(2) treatment on plasma somatostatin (SS)-14 and -25 concentrations in sexually immature rainbow trout (Oncorhynchus mykiss), were investigated. E(2) treatment significantly (P < 0.001) depressed both plasma SS-14 and SS-25. In the hypothalamus, E(2) treatment significantly (P < 0.001) decreased the levels of PPSS I and PPSS II" mRNA. However, there was no effect of E(2) treatment on PPSS II' mRNA levels. In the pancreas, E(2) treatment had no significant effect on the levels of either PPSS II' mRNA or PPSS II" mRNA. However, E(2) treatment significantly (P < 0.005) decreased levels of PPSS I mRNA. These data suggest that E(2) acts, in part, to increase plasma growth hormone levels in rainbow trout by decreasing the endogenous inhibitory somatostatinergic tone by inhibiting plasma levels of both SS-14 and SS-25 and hypothalamic levels of mRNA encoding these proteins.
Subject(s)
Estradiol/pharmacology , Gene Expression/drug effects , Oncorhynchus mykiss/genetics , Somatostatin/genetics , Animals , Estradiol/physiology , Gene Expression Regulation/physiology , RNA, Messenger/metabolism , Somatostatin/bloodABSTRACT
We previously characterized two cDNAs that encode for distinct preprosomatostatin molecules containing [Tyr(7), Gly(10)]-somatostatin-14 at their C-termini (PPSS II' and PPSS II") and found that these cDNAs were differentially expressed in the endocrine pancreas (Brockmann body) of rainbow trout, Oncorhynchus mykiss. In this study, we examined the control of PPSSII' mRNA and PPSS II" mRNA expression by glucose. Fish injected with glucose displayed elevated plasma levels of glucose in association with nearly three-fold higher levels of PPSS II mRNAs compared to saline-injected control animals. Glucose directly stimulated the expression of both PPSS II mRNAs in vitro in a dose-dependent manner; however, glucose was a more potent stimulator of PPSS II" expression than of PPSS II' expression. The hexoses, mannose, galactose, and fructose, as well as glucose, all induced the expression of PPSS II mRNAs, whereas, sucrose and the glucose analogs, 3-o-methylglucose and 2-deoxyglucose, were without effect. In addition, the expression of PPSS II mRNAs was stimulated by dihydroxyacetone, pyruvate, lactate, acetate, and citrate. Furthermore, the expression of PPSS II mRNAs was inhibited by iodoacetate, an inhibitor of glycolysis, but was stimulated by dichloroacetate, a stimulator of Krebs cycle flux via pyruvate dehydrogenase activation. Finally, glucose-stimulated PPSS II expression was inhibited by actinomycin. These results indicate that the expression of PPSS II mRNAs in the Brockmann body of trout is regulated by nutrients such as glucose and suggest that glucose-stimulated expression of PPSS II mRNAs requires the uptake and subsequent metabolism of the sugar and is transcription sensitive.
Subject(s)
Glucose/pharmacology , Islets of Langerhans/metabolism , Oncorhynchus mykiss/metabolism , Protein Precursors/biosynthesis , RNA, Messenger/biosynthesis , Somatostatin/biosynthesis , Animals , Blood Glucose/metabolism , Citric Acid Cycle/drug effects , Dactinomycin/pharmacology , Female , Glycolysis/drug effects , Hexoses/pharmacology , Islets of Langerhans/drug effects , Male , Nucleic Acid Synthesis Inhibitors/pharmacology , Sucrose/pharmacologyABSTRACT
Rainbow trout were used as a model system to evaluate the role of glucose in regulating the expression of preprosomatostatin I. Glucose increased pancreatic levels of preprosomatostatin I mRNA in vivo, in concert with elevated plasma somatostatin levels, and in vitro. Glucose-stimulated expression of preprosomatostatin I mRNA required the uptake, phosphorylation, and subsequent metabolism of the sugar in pancreatic islets. These results suggest that glucose modulates both the production and release of somatostatin.
